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β1-adrenergic receptor  
contains Multiple iak and iek  
Binding epitopes That induce T cell 
responses with Varying Degrees of 
autoimmune Myocarditis in a/J Mice
Rakesh H. Basavalingappa1, Chandirasegaran Massilamany1†, Bharathi Krishnan1, 
Arunakumar Gangaplara1†, Rajkumar A. Rajasekaran1, Muhammad Z. Afzal2,  
Jean-Jack Riethoven3, Jennifer L. Strande2, David Steffen1 and Jay Reddy1*
1 School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States, 
2 Department of Medicine, Division of Cardiology, Medical College of Wisconsin, Milwaukee, WI, United States,  
3 Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, United States
Myocarditis/dilated cardiomyopathy (DCM) patients can develop autoantibodies to var-
ious cardiac antigens and one major antigen is β1-adrenergic receptor (β1AR). Previous 
reports indicate that animals immunized with a β1AR fragment encompassing, 197–222 
amino acids for a prolonged period can develop DCM by producing autoantibodies, but 
existence of T cell epitopes, if any, were unknown. Using A/J mice that are highly suscep-
tible to lymphocytic myocarditis, we have identified β1AR 171–190, β1AR 181–200, and 
β1AR 211–230 as the major T cell epitopes that bind major histocompatibility complex 
class II/IAk or IEk alleles, and by creating IAk and IEk dextramers, we demonstrate that the 
CD4 T cell responses to be antigen-specific. Of note, all the three epitopes were found 
also to stimulate CD8 T cells suggesting that they can act as common epitopes for both 
CD4 and CD8 T cells. While, all epitopes induced only mild myocarditis, the disease- 
incidence was enhanced in animals immunized with all the three peptides together as 
a cocktail. Although, antigen-sensitized T cells produced mainly interleukin-17A, their 
transfer into naive animals yielded no disease. But, steering for T helper 1 response 
led the T cells reacting to one epitope, β1AR 181–200 to induce severe myocarditis in 
naive mice. Finally, we demonstrate that all three β1AR epitopes to be unique for T cells 
as none of them induced antibody responses. Conversely, animals immunized with a 
non-T  cell activator, β1AR 201–220, an equivalent of β1AR 197–222, had antibodies 
comprising of all IgG isotypes and IgM except, IgA and IgE. Thus, identification of T cell 
and B  cell epitopes of β1AR may be helpful to determine β1AR-reactive autoimmune 
responses in various experimental settings in A/J mice.
Keywords: autoimmunity, β1-adrenergic receptor, myocarditis, mouse model, T cells
inTrODUcTiOn
Myocarditis is one major cause of dilated cardiomyopathy (DCM) that can lead to heart failure in 
young adults in the developed countries. Approximately, half of those affected with DCM undergo 
heart transplantation due to lack of effective therapeutic options (1–4). Clinically, majority of DCM 
patients (up to 80%) are designated to be idiopathic DCM (IDCM), and the detection of heart 
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infiltrates in those affected suggests that immune dysfunction 
may be an underlying mechanism in the DCM pathogenesis 
(5–8). Growing evidence suggests that autoimmune responses 
may be an important trigger, since DCM patients can show 
autoantibodies for various antigens such as cardiac myosin, 
cardiac troponin I, adenine nucleotide translocator 1 (ANT), 
β1-adrenergic receptor (β1AR), and branched chain alpha-
ketoacid dehydrogenase (BCKD) (9–12). For example, β1AR-
reactive antibodies can be detected in 26–60% of IDCM patients 
as compared to ischemic cardiomyopathy (10–13%) or healthy 
controls (<10%) (6, 7, 13). While, DCM patients can show anti-
body reactivity to cardiac myosin heavy chain-α (Myhc) (66%) 
and troponin-I (50%), up to 80% of the end-stage IDCM patients 
or more than 90% of patients using left ventricular assist device 
were shown to be positive for antibodies to β1AR (6, 7). These 
observations suggest that β1AR may be a major autoantigen in 
the initiation and progression of DCM.
β-adrenergic receptors are classified into four subtypes with 
β1AR being found primarily in the heart, whereas β2AR is 
expressed in the lung, kidney, blood vessels and heart, and 
β3AR-expression occurs primarily in the adipose tissue (14, 15). 
Although, mRNA and protein data are lacking, existence of β4AR 
has been reported, which appears to represent the low-affinity 
state of β1AR (16). Belonging to G-protein-coupled receptors, 
β1AR contains three each of extracellular (EC) and intracellular 
loops. The natural ligands of β1AR namely, adrenaline and nor-
adrenaline trigger activation of cyclic adenosine monophosphate 
(cAMP) and protein kinase A leading to influx of calcium 
(Ca2+) through L-type Ca2+ channel and cardiac contractility 
(17, 18). Similar events can be expected under conditions of 
autoimmunity as might occur with the presence of β1AR-reactive 
autoantibodies. In fact, antibodies recognizing epitopes localized 
within the EC loops, particularly EC loop II (β1AR 197–222), can 
agonistically trigger Ca2+ release and cAMP activation, without 
affecting interaction of β1AR with its natural ligands (6, 19). Such 
antibodies have been detected in DCM patients indicating their 
pathological significance (13, 20).
Experimentally, monthly immunizations for 6–18  months 
with β1AR 197–222 can result in the production of antibodies 
in various species such as rabbits, rats, and mice, and the immu-
nized animals can develop features of cardiomyopathy during the 
course of ~1 year with little or no myocarditis (21–25). While, an 
assumption made in these studies that a single epitope of β1AR 
can act as an immunogen in various species despite the major 
histocompatibility complex (MHC) alleles to be different was 
found valid, identification of other potential immunodominant 
epitopes, if any, was not explored. Likewise, it was unknown 
whether β1AR possesses T  cell epitopes and contributes to 
disease. This is particularly important because, for B  cells to 
produce antibodies of different isotypes, T cell help is critical, 
and identification of T cell epitopes may thus provide another 
layer of evidence for pathologic importance of β1AR in the DCM 
pathogenesis. To this end, we sought to characterize the T cell 
epitopes of β1AR in A/J mice that are highly susceptible to lym-
phocytic myocarditis leading us to identify several epitopes that 
induce differential T cell and/or antibody responses. By testing 
for myocarditogenicity, we noted that the antigen-primed T cells 
could induce severe myocarditis in naive recipients, but the 
T cells needed to produce primarily, T helper (Th) 1 cytokines, 
in addition to Th17 cytokines.
MaTerials anD MeThODs
Mice
Six- to eight-week-old, female A/J mice (H-2a) procured from the 
Jackson Laboratory (Bar Harbor, ME, USA) were maintained in 
accordance with the institutional guidelines of the University of 
Nebraska-Lincoln. Approval for animal studies was granted by 
the Institutional Animal Care and Use Committee, University 
of Nebraska-Lincoln, Lincoln, NE, USA (protocol #: 1398). 
Euthanasia was performed using a carbon dioxide chamber 
as recommended by the Panel on Euthanasia, the American 
Veterinary Medical Association.
Peptide synthesis
An overlapping peptide library that included a total of 46 pep-
tides of 20-mers, except one peptide, β1AR 451–466 (16-mer) 
was created. In addition to these, bovine ribonuclease (RNase) 43–56 
(VNTFVHESLADVQA), biotinylated hen egg lysozyme (HEL) 
46–61 (YNTDGSTDYGILQINSR) (Neopeptide, Cambridge, MA, 
USA), and moth cytochrome c (MCC) 82–103 (FAGLKKANER 
ADLIAYLKQATK) (GenScript, Piscataway, NJ, USA) were synt-
hesized by 9-fluorenylmethyloxycarbonyl chemistry. Where indi-
cated, acetylated β1AR (β1ARAc) that contain acetyl group at the 
N-terminal end were used. All peptides were high-performance 
liquid chromatography-purified (>90%), and their identities 
were confirmed by mass spectroscopy. Ultrapure water was used 
to dissolve peptides and stored at −20°C.
immunization Procedures
Peptide emulsions were prepared in complete Freund’s adjuvant 
(CFA) containing Mycobacterium tuberculosis H37RA extract 
(Difco Laboratories, Detroit, MI, USA) to a final concentration 
of 5 mg/ml. To induce disease, animals were immunized twice 
s.c., in inguinal and sternal regions on days 0 and 7, and all ani-
mals received pertussis toxin (PT, List Biological Laboratories, 
Campbell, CA, USA; 100 ng/mouse) i.p., on days 0 and 2 after 
the first immunization (26–29). In pooled settings, 50 µg of each 
peptide was used, and when peptides were used individually, 
Abbreviations: DCM, dilated cardiomyopathy; β1AR, β1-adrenergic receptor; 
β1ARAc, N-terminal acetylated β1-adrenergic receptor; IDCM, idiopathic dilated 
cardiomyopathy; ANT, adenine nucleotide translocator 1; BCKD, branched 
chain alpha-ketoacid dehydrogenase; Myhc, cardiac myosin heavy chain-α; EC, 
extracellular; cAMP, cyclic adenosine monophosphate; MHC, major histocompat-
ibility complex; Th, T helper; RNase, bovine ribonuclease; HEL, hen egg lysozyme; 
MCC, moth cytochrome c; CFA, complete Freund’s adjuvant; PT, pertussis toxin; 
H&E, hematoxylin and eosin; IHC, immunohistochemistry; Abs, antibodies; RT, 
room temperature; HRP, horseradish peroxidase; LV, left ventricle; LVID, left 
ventricular internal diameter; RWT, relative wall thickness; BSA, body surface area; 
3[H]-thymidine, tritiated-thymidine; cpm, counts per minute; SA, streptavidin; 
DELFIA, dissociation-enhanced lanthanide fluoroimmunoassay; LNCs, lymph 
node cells; 7-AAD, 7-aminoactinomycin-D; dext+, dextramer+; IL, interleukin; 
IFN, interferon; TNF, tumor necrosis factor; LPS, lipopolysaccharide; MNCs, 
mononuclear cells; T. cruzi, Trypanosoma cruzi.
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100 µg was used per animal. To measure T cell responses in some 
experiments, a single dose of peptide emulsions were used.
histology
Hearts, and non-cardiac tissues (brain, lung, liver, and kidney) 
collected at termination on day 21 postimmunization were fixed 
by immersing in 10% phosphate-buffered formalin (26, 28). 
Longitudinal tissue layers were cut from hearts, and also from 
non-cardiac tissues. Serial sections with 5  µm thickness were 
then obtained and stained with hematoxylin and eosin (H&E). 
Analysis was performed by a board-certified pathologist blinded 
to treatment. After ascertaining the inflammatory changes, total 
number of inflammatory foci were determined by sections with 
the largest number of foci or by adding non-overlapping foci 
across sections as reported previously (26, 28, 30, 31).
immunohistochemistry (ihc)
To detect T  cells in hearts, formalin-fixed paraffin-embedded 
tissue sections were stained with rabbit anti-mouse CD3 (clone 
SP7, 1:100, Abcam, Cambridge, MA, USA), rabbit anti-mouse 
CD4 (polyclonal, 1:100, Novus Biologicals, Littleton, CO, USA), 
and rabbit anti-mouse CD8 (clone EP1150Y, 1:100, Novus 
Biologicals) or their isotype controls. For non-T  cells namely, 
neutrophils, macrophages, and B  cells, rat anti-mouse Ly6G 
(clone 1A8, 1:250, Leinco Technologies, Fenton, MO, USA), 
rabbit anti-mouse CD11b (clone EPR1344, 1:3,500, Abcam) 
(30), and rat anti-mouse CD19 (clone 6OMP31, 1:1000, Thermo 
Fisher Scientific, San Diego, CA, USA) and their isotype con-
trols were used, respectively. In brief, after deparaffinization, 
rehydration, and blockade of endogenous peroxidase activity, 
antigen retrieval was performed by treating the sections with 
10 mM sodium citrate buffer (pH 6.0) in a water bath at 98°C 
for 15–40  min or using a pressure cooker. Sections were then 
blocked with 5% non-fat dry milk for 30 minutes, incubated with 
primary antibodies (Abs) at 4°C overnight; followed by incuba-
tion with horseradish peroxidase (HRP)-conjugated, goat anti-
rabbit IgG or goat anti-rat IgG (Abcam) as secondary antibodies 
for 2  h at room temperature (RT). Diaminobenzoic acid was 
used as a substrate for color development before counterstain-
ing with hematoxylin (26, 30). For quantitative analysis (T cells: 
CD3+, CD4+, and CD8+; and non-T cells: Ly6G+, CD11b+, and 
CD19+) in the heart, five random areas were selected from the 
representative sections and nuclear staining was confirmed using 
nuclear V9 software (Aperio Technologies, Vista, CA, USA). Cells 
positive for each marker were then enumerated and normalized 
to 1 mm2 area using Aperio ImageScope Analysis Software (Leica 
Biosystems, MN, USA) as we have described previously (30).
echocardiography and image analysis
Transthoracic echocardiography was performed in anesthe-
tized animals immunized with or without a cocktail of β1ARAc 
171–190, β1ARAc 181–200, and β1ARAc 211–230 on day 20. 
Scanning was performed by a research sonographer, blinded 
to the study groups, using a commercially available echocar-
diography system (Vivid 7, General Electric, Wauwatosa, WI, 
USA) with an M12-L linear array transducer as we reported 
previously (30). The mice were anesthetized with isoflurane 
and images were captured in the short-axis view at the mid-left 
ventricle (LV) level, verified by the presence of prominent papil-
lary muscles. Three consecutive cardiac cycles, defined from 
the peak of one R wave to the peak of the following R wave 
were measured and used for analysis as previously reported 
(30). In brief, linear measurements were performed using the 
M-mode view to assess width of the intraventricular septum 
at diastole and the internal diameter of the LV at diastole and 
systole. The Teichholz formula {LV volume  =  [7/2.4  +  left 
ventricular internal diameter (LVID)]  ×  LVID3} was used to 
calculate end-diastolic and end-systolic volumes (30). The 
relative wall thickness (RWT) was calculated as the ratio of 
2  ×  LV posterior wall thickness and LV internal diameter at 
end-diastole. The RWT normal range is between 0.32 and 0.42. 
Total body surface area (BSA) was calculated using the Meeh’s 
formula (BSA = 10 × [weight]2/3) (32). All measurements were 
indexed to BSA to account variation in size.
T cell Proliferation assay
At termination, lymph nodes (maxillary, mandibular, axillary, 
inguinal, and popliteal) and spleens were harvested from 
immunized animals to prepare single cell suspensions. Similarly, 
splenocytes were prepared from naive animals. After lysing the 
erythrocytes and washing, cell pellets were suspended in RPMI 
medium containing 10% fetal bovine serum, 1 mM sodium pyru-
vate, 4 mM l-glutamine, 1 × each of non-essential amino acids 
and vitamin mixture, and 100  U/ml penicillin–streptomycin 
(Lonza, Walkersville, MD, USA; hereafter called growth 
medium). In some experiments, CD4 T  cells and CD8 T  cells 
were enriched to a purity of ~95% by negative selection based 
on magnetic separation using IMAG (BD Biosciences, San Jose, 
CA, USA) (31). To stimulate CD4 and CD8 T  cells, syngeneic 
naive irradiated splenocytes loaded with peptides were used as 
antigen-presenting cells at a ratio of 1:1. Cells were stimulated 
at a density of ~5 × 106 cells/ml in triplicates with or without the 
immunizing peptides (0–100 µg/ml) in growth medium. RNase 
43–56 or HEL 46–61 were used as irrelevant controls. After 2 days, 
cells were pulsed with tritiated 3[H]-thymidine (1 μCi/well; MP 
Biomedicals, Santa Ana, CA, USA), and 16 h later, proliferative 
responses were measured as counts per minute (cpm) using a 
Wallac liquid scintillation counter (Perkin Elmer, Waltham, MA, 
USA) (26, 28, 30).
Mhc class ii-Binding assay
A/J mice express two MHC class II alleles, IAk and IEk (33, 34), 
and to determine the affinities of β1AR peptides, soluble 
IAk and IEk monomers were expressed (34, 35). In brief, the 
β-chain in each of IAk and IEk constructs contain sequence 
for class II-associated invariant-chain peptide 88–102 
(VSQMRMATPLLMRPM) linked with thrombin cleavage 
site (34, 35). After expressing in the baculovirus, soluble IAk 
and IEk monomers were treated with thrombin (20  U/mg; 
Novagen, Madison, WI, USA) to release class II-associated 
invariant-chain peptide leading us to obtain empty IAk and 
IEk molecules. Reaction mixtures were prepared to include 
empty IAk or IEk monomers (0.35  µg), competitor peptides 
(β1ARAc 171–190, β1ARAc 181–200, β1ARAc 201–220, and β1ARAc 
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211–230) (0.00001–100  µM), and constant amounts of the 
biotinylated reference peptides HEL 46–61 (for IAk) or MCC 
82–103 (for IEk) (1 µM) in a buffer containing 50 mM sodium 
phosphate pH 7.0, 100  mM sodium chloride, 1  mM EDTA, 
and 1  ×  protease inhibitor (Sigma-Aldrich, St. Louis, MO, 
USA) (36–38). After incubating overnight at RT, the mixtures 
were transferred to 96-well white fluorescence plates coated 
with anti-IAk (clone 10-2.16, BioXcell, West Lebanon, NH, 
USA), and anti-IEk (clone M5/114, BioXcell) Abs (10  µg/ml) 
in 0.2  M sodium phosphate buffer, pH 6.8, blocked with 2% 
bovine casein; and the plates were incubated on a rocker at 
RT for 1  h. Finally, after adding 100  µl of europium-labeled 
streptavidin (0.1 µg/ml) and dissociation-enhanced lanthanide 
fluoroimmunoassay (DELFIA) enhancement solution (Perkin 
Elmer) sequentially, fluorescence intensities were measured at 
excitation/emission wavelengths of 340/615 nm using a Victor 
Multilabel Plate Reader (Perkin Elmer). The IC50 values were 
determined based on the concentrations of competitor peptides 
needed to prevent 50% binding of the reference peptides as we 
have described previously (26, 28, 30).
creation of Mhc class ii/iak  
or iek Dextramers to Determine  
antigen-specificity of T cells
To enumerate the frequencies of antigen-specific CD4 T cells, we 
created IAk dextramers for β1AR 171-190 and β1AR 211–230, and 
IEk dextramers for β1AR 181–200. To create IAk dextramers, the 
nucleotide sequence for β1AR 171–190 (acgcgcgcgcgagcgcgggc-
cctcgtgtgcacagtgtgggccatctcggcgttggtgtcc) and β1AR 211–230 
(aacgaccccaagtgctgcgatttcgtcaccaacagggcctacgccatcgcctcgtccgtc) 
was inserted into the IAk-β construct that we had described 
previously (35, 39), whereas IAk/RNase 43–56 (control) dex-
tramers were readily available in our laboratory (30, 35, 40). The 
soluble, IAk/β1AR 171–190 and IAk/β1AR 211–230 molecules 
were expressed in sf9 cells using baculovirus expression system. 
After purifying through anti-IAk-affinity column, the IAk/β1AR 
171–190 and IAk/β1AR 211–230 monomers were biotinylated and 
dextramers were derived using streptavidin (SA)/fluorophore-
conjugated dextran molecules as described previously (35, 39). 
IEk/β1AR 181–200 and IEk/MCC 82–103 (control) dextramers 
were prepared based on peptide-exchange reaction as we have 
described previously (34).
To stain with dextramers, lymphocytes obtained from lymph 
nodes and spleens from immunized animals were stimulated 
with the immunizing peptides namely, β1ARAc 171–190, β1ARAc 
181–200, and β1ARAc 211–230 (20 µg/ml) for 2 days and growth 
medium containing interleukin (IL)-2 (IL-2 medium) was then 
added. After harvesting viable cells by ficoll density-gradient cen-
trifugation on day 5, cells were rested in the IL-2 medium. During 
7–10  days poststimulation, cells were stained with IAk-[β1ARAc 
171–190 (37°C) or β1ARAc 211–230 (RT), and RNase 43–56, 
control] or IEk-dextramers [β1ARAc 181–200 (RT) and MCC 
82–103, control] followed by anti-CD4 and 7-aminoactinomycin-
D (7-AAD). After washing, and acquisition by flow cytometry, 
percent dextramer+ (dext+) cells were analyzed within the live 
cells (7-AAD−) using Flow Jo software (34, 35, 39).
cytokine secretion
Supernatants were obtained from lymph node cell (LNC) cultures 
prepared from immunized animals that were stimulated with 
or without acetylated or non-acetylated, β1AR 171–190, β1AR 
181–200, and β1AR 211–230 and RNase 43–56/HEL 46–61 
(controls) (50–100 µg/ml) on day 3 poststimulations. Cytokine 
analysis was performed using beads conjugated with capture 
and detection Abs with the standard curves being derived from 
serial dilutions of mouse cytokine standard mixtures, consisting 
of IL-2, interferon (IFN)-γ, IL-4, IL-6, IL-10, IL-17A, and tumor 
necrosis factor (TNF)-α as recommended by the manufacturer’s 
guidelines (BD Biosciences). Briefly, capture bead/cytokine 
antibody conjugates were first prepared, and the mixtures were 
added to a tube containing diluted standards or test samples, 
followed by addition of detection antibodies. After acquiring by 
flow cytometry, FCAP Array Software was used to analyze the 
data (BD Biosciences) (26, 30).
induction of Myocarditis by adoptive 
Transfer of antigen-sensitized T cells
Lymph node cells obtained from animals immunized with 
individual peptides, β1ARAc 171–190, β1ARAc 181–200, or β1ARAc 
211–230 on day 21 postimmunizations were stimulated with the 
corresponding immunizing peptides (20 µg/ml) for 2 days fol-
lowed by resting in IL-2 medium. In a separate set of experiments, 
animals were immunized with a mixture of β1ARAc 171–190, 
181–200, and 211–230 peptides and their lymphocytes were 
stimulated with the immunizing peptides individually (50  µg/
ml) for 2 days and then IL-2 medium was added. On day 3, one 
of the two aliquots of cells were exposed to a mixture of Th1- and 
Th17-polarizing conditions by adding recombinant mouse IL-12 
(20 ng/ml), IL-1β (30 ng/ml), IL-6 (30 ng/ml), IL-23 (50 ng/ml) 
(all cytokines were procured from BioLegend, San Diego, CA, 
USA), and human transforming growth factor-β1 (10  ng/ml; 
eBioscience, San Diego, CA, USA) as reported previously (41–44), 
and the other was maintained in IL-2 medium alone. Flow cyto-
metrically, we analyzed the percentages of cytokine-producing 
cells on days 3 and 6 following polarization as we have described 
previously (28, 31, 40). Viable cells harvested on days 8–10 were 
administered through i.p., or retro-orbital sinus (4–14 × 106 cells/
animal) into naive mice primed with lipopolysaccharide (LPS, 
25 µg/mouse i.p., day −4 and day 0). PT was administered i.p., 
(100 ng/mouse) on days 0 and 2 posttransfer (26, 30, 45). Saline 
recipients and the LPS/PT-primed naive mice were used as con-
trols. Animals were euthanized on 14–21 days after transfer to 
collect hearts for histology.
Detection of antibodies That react  
with β1arac Peptides
ELISA was used to measure antibodies that react with β1ARAc 
peptides in the serum samples collected from immunized 
animals at termination on day 21 as described previously (26). 
Microtiter polystyrene plates were coated with or without β1ARAc 
171–190, β1ARAc 181–200, β1ARAc 191–210, β1ARAc 201–220, and 
β1ARAc 211–230 or irrelevant control (RNase 43–56) (10 µg/ml) 
in 1 × coating buffer (eBioscience) and the plates were incubated 
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at 4°C overnight. After washing/blocking, serum samples (1:100) 
were added in duplicates, and the plates were incubated at 37°C 
for 1  h followed by addition of HRP-labeled goat anti-mouse 
immunoglobulins (Igs), IgG1, IgG2a, IgG2b, IgG3, IgM, IgA, 
and IgE (Southern Biotech, Birmingham, AL, USA) as secondary 
antibodies. Two hours after incubation at RT, 1 × tetramethylb-
enzidine solution was added as a substrate (eBioscience), and 
reactions were stopped using 1  M phosphoric acid. The plates 
were read at 405 nm using an automated ELISA reader (BioTek 
instruments, Winooski, VT, USA) to measure OD values (26, 46).
statistics
Kruskal–Wallis test was used to compare differences in cytokine 
production, inflammatory foci and antibodies where more than 
two groups were involved. When significant differences were 
noted (P < 0.05), analyses were continued with post hoc tests via 
Dunn–Sidak multiple test correction. Differences in the incidence 
of myocarditis between groups were compared using the Fisher’s 
exact test. Student’s t-test was used to determine differences in 
the T cell proliferative responses, echocardiography parameters, 
MHC-binding affinities, frequencies of dext+ cells, and cytokine 
producing cells.
resUlTs anD DiscUssiOn
In this report, we describe identification of T  cell epitopes of 
β1AR in A/J mice that are highly susceptible to lymphocytic myo-
carditis induced by various cardiac antigens namely, Myhc (28), 
cardiac troponin I (47), ANT (26), and BCKD kinase (30). Impor-
tance of β1AR in the cardiac disease has long been investigated in 
that patients with myocarditis/DCM, in particular, IDCM show 
β1AR-reactive antibodies. Such a reactivity has been proposed 
to signify a marker of disease-progression and/or to predict 
prognosis (6, 20). β1AR-reactive antibodies localized to EC loop 
II particularly for β1AR 197–222 was also helpful to screen DCM 
patients in clinical settings (13, 48). Because the sequence of β1AR 
197–222 is found conserved with 100% identity between humans, 
mice and rats, and 96.1% with rabbits (Table S1 in Supplementary 
Material), perhaps, rodent studies were undertaken to determine 
the pathogenic significance of β1AR 197–222 in the development 
of myocardial disease. Expectedly, rats and rabbits immunized 
with β1AR 197–222 developed cardiac dysfunctions suggestive 
of DCM, with minimal or no heart infiltrates (21–25). But all 
these disease-inducing protocols required biweekly or monthly 
immunizations for a period of 6–18 months. In addition, animals 
immunized with β1AR had agonistic antibodies of IgG isotype 
that trigger cardiac arrhythmias by activating cAMP/protein 
kinase A pathway and apoptosis of cardiomyocytes (19). In these 
conditions, however, relevance of β1AR-reactive T cell responses 
in the causation of cardiac autoimmunity remained uninvesti-
gated. Thus, we made efforts to identify T cell epitopes of β1AR 
and their ability to induce myocarditis in A/J mice.
To identify T cell epitopes, we created an overlapping peptide 
library that included 46 peptides of 20-mers spanning the entire 
length of mouse β1AR (466 amino acids; Table S2 in Supplementary 
Material). For initial screening, we made nine pools with four to 
five peptides in each, and immunized A/J mice using the standard 
myocarditis-inducing protocol by administering peptide emul-
sions twice with a week interval as we and others have reported 
for various cardiac antigens (26, 28, 49). These analyses revealed 
detection of myocarditis in animals that received peptides from 
pools namely, IV, VII, VIII, and IX, with a disease incidence of 
20–40% and the inflammatory foci were in the range of 2–42 
(Table S3 in Supplementary Material). However, by evaluating 
T  cell responses using RNase 43–56 as an irrelevant control, 
a trend was noted in that animals receiving a pool of peptides 
starting from β1AR 171–190 to β1AR 211–230 (pool IV) had good 
T cell responses up to ~2- to 5-fold that also had diffused inflam-
matory foci in one animal (Table S3 in Supplementary Material). 
Similar pattern was noted for one other group (pool VII) 
with the proliferative responses noted up to two-fold for three 
peptides (β1AR 321–340, β1AR 351–370, and β1AR 361–380), 
whereas T cell responses were not significant in the peptide pools, 
VIII and IX (Table S3 in Supplementary Material). Likewise, 
significant T cell responses although noted for few peptides in 
pools, I, II, III, V, and VI, inflammation was absent in the hearts of 
immunized animals (Table S3 in Supplementary Material). These 
observations suggest that occurrence of myocarditis might not be 
due to T cell responses in all the pools.
Since, our intent was to identify T cell epitopes which are capa-
ble to induce myocarditis, and the peptides spanning a stretch 
of 60 aa (β1AR 171–230, pool IV; Table S3 in Supplementary 
Material) that also encompasses β1AR 197–222 which was previ-
ously reported to be a B cell epitope (13, 48), we focused on all the 
five peptides from pool IV (Table S4 in Supplementary Material). 
For comparative analysis, we also randomly chose two other pep-
tides from pool VIII namely; β1AR 381–400 and β1AR 391–410 
that did not show T cell responses, but showed myocarditis (Table 
S3 in Supplementary Material). In the individual immunization 
settings, the disease incidence was noted to be 20–40%, but 
unexpectedly, none of the animals had significant disease, except 
two peptides that induced mild disease (β1AR 181–200 and β1AR 
211–230) (Table S4 in Supplementary Material).
We and others had previously reported that the peptides 
modified to include acetyl group at N-terminal end can induce 
significant myocarditis such as Myhc 614–643 in Balb/c mice 
(26, 29). It has been proposed that acetylated peptides can be 
prevented from intracellular degradation leading to their stable 
binding to MHC molecules (29, 50). Thus, we decided to use 
the acetylated peptides, and focused only the peptides that were 
located within the stretch of β1AR 171–230 (Table 1). While, some 
enhancement was noted with the ability of acetylated peptides 
(β1ARAc 171–190 and β1ARAc 181–200) to induce myocarditis, 
only 25% of animals had the disease (Table 1). Expectedly, hearts 
from control groups (naive and CFA/PT) were negative for 
inflammatory changes. The T cell responses however were con-
sistently noted for β1ARAc 171–190, β1ARAc 181–200, and β1ARAc 
211–230 (Figure 1), whereas β1ARAc 191–210 and β1ARAc 201–220 
remained as non-T cell activators (Figure S1A in Supplementary 
Material). The proliferative responses noted in the immunized 
animals were dose-dependent, and also specific to antigen, since 
responses to control antigen (RNase 43–56/HEL 46–61) were 
lacking (Figure 1). We then asked whether T cells primed with 
a pool of all three peptides that showed T cell responses (β1ARAc 
FigUre 1 | T cell responses induced by β1ARAc peptides. Lymph node cells (LNCs) obtained from animals immunized with β1ARAc 171–190, β1ARAc 181–200, and 
β1ARAc 211–230 were restimulated with or without the corresponding peptides and RNase 43–56/HEL 46–61 (negative control) for 2 days. After pulsing with 
3[H]-thymidine for 16 h, proliferative responses were measured as cpm. Mean ± SEM values derived from three to four individual experiments, each involving three 
to eight mice are shown. *P < 0.05 and **P < 0.01 vs. negative controls.
TaBle 1 | Induction of myocarditis by β1ARAc peptides.
groups incidence (%) inflammatory focia
Naive 0/6 (0) 0
CFA/PT 0/6 (0) 0
β1ARAc 171–190 3/12 (25) 2.7 ± 1.2
β1ARAc 181–200 3/12 (25) 3.7 ± 1.8
β1ARAc 191–210 0/5 (0) 0
β1ARAc 201–220 1/5 (20) 13
β1ARAc 211–230 2/12 (17) 1.0 ± 0.0
β1ARAc 171–190, 181–200, and 211–230 5/8 (63)* 2.8 ± 1.1
aRepresents mean ± SEM values derived from myocarditic animals.
*P < 0.05 vs. controls.
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171–190, β1ARAc 181–200, and β1ARAc 211–230) can collectively 
contribute to myocarditis-induction. These experiments led us to 
note a significant increase in the disease incidence (63%), but the 
disease-severity remained unaltered (Table 1, P = 0.03).
Histologically, in contrast to normal heart sections, inflam-
matory foci consisting of mononuclear cells (MNCs) involving 
pericardium, myocardium and endocardium were detected in 
animals immunized with β1ARAc 171–190, β1ARAc 181–200, or 
β1ARAc 211–230 individually or as a mixture, but necrosis or 
fibrosis were absent (Figure  2A). Consistent with these obser-
vations, echocardiographic analysis also revealed mild cardiac 
abnormalities as indicated by trends with increased heart rate 
relative to control animals (384.0  ±  10.10 vs. 337.67  ±  20.98 
beats/min; P  =  0.08, Table S5 in Supplementary Material). 
Immunized animals showed decreased LVID index at end-systole 
(0.26  ±  0.01 vs. 0.33  ±  0.01  mm; P  =  0.047) and end-systolic 
volume (17.50 ± 2.89 vs. 33.33 ± 8.33 µl; P = 0.09, Table S5 in 
Supplementary Material) associated with an increase in left 
ventricular systolic function reported as ejection fraction and 
fractional shortening. The immunized mice showed the absence 
of hypertrophy and dilation as indicated by the lack of significant 
increase in the diastolic septal/posterior wall thickness indices 
and end-diastolic volume. However, the RWT of 0.43 in the 
immunized mice (normal RWT = 0.32–0.42) identifies concentric 
remodeling without hypertrophy whereas RWT of 0.39 identifies a 
normal morphology as seen in the naive mice (51). No differences 
with body weight (19.20 ± 0.32 vs. 18.23 ± 0.44 g), heart weight 
(87.25 ±  1.11 vs. 84.00 ±  1.73  mg) or heart/body weight ratio 
(4.55 ± 0.03 vs. 4.61 ± 0.07 mg/g) were observed between immu-
nized and control groups (Figure S2 in Supplementary Material). 
Previous reports indicate that rats immunized with β1AR 197–222 
for a prolonged period showed early cardiomyopathic changes at 
1 year, but with no necrosis or fibrosis including changes in heart 
to body weight ratios (21). Likewise, cardiac abnormalities could 
be detected in Balb/c mice only at 25 weeks but not at 14 weeks 
postimmunization (22). These observations support the notion 
that β1AR-induced cardiomyopathy may be a slow progressive 
disease.
Nonetheless, we further characterized the immune cells by 
IHC and the analysis revealed that heart sections from animals 
immunized with a mixture of three peptides as indicated above 
had CD3+ (136 ± 9 cells/mm2), CD4+ (92 ± 1 cells/mm2), CD8+ 
(66 ±  21  cells/mm2) T  cells, and CD11b+ (65 ±  13  cells/mm2) 
macrophages, whereas Ly6G+ neutrophils, and CD19+ B  cells 
were absent (Figure  2B: bottom panel). Expectedly, sections 
from control groups were negative for all the markers tested 
except rare CD11b+ cells. While, detection of T  cells, mainly 
CD4 T cells and macrophages suggest the features of delayed-type 
hypersensitivity (DTH) reaction as noted with other myocarditis 
models (26, 28–30), detection of CD8 T cells was not expected 
although they can form a component of DTH reaction. This 
led us to test a possibility that both CD4 and CD8 T cells may 
have a role in myocarditis-induction. We sorted both subsets of 
T  cells by magnetic separation from animals immunized with 
β1ARAc 171–190, β1ARAc 181–200, or β1ARAc 211–230 to a purity 
of ~95% (Figure S3A in Supplementary Material), and tested their 
ability to respond to antigens in a proliferation assay. As shown 
in Figure S3B in Supplementary Material, both CD4 and CD8 
T  cells responded to the corresponding immunizing peptides 
dose-dependently, and also antigen-specifically, since responses 
to HEL 46–61 were lacking. While, these data suggest that the 
disease induced with β1ARAc 171–190, β1ARAc 181–200, and 
β1ARAc 211–230 might have involved the mediation of both CD4 
and CD8 T cells, existence of three CD8 T cell epitopes in as many 
CD4 T cell epitopes for a single autoantigen is unusual. But, we 
and others have previously reported that CD4 T cell epitopes of 
FigUre 2 | Histological evaluation of hearts from animals immunized with β1ARAc peptides. (a) Hematoxylin and eosin (H&E) staining. Groups of mice were 
immunized with or without indicated peptides in complete Freund’s adjuvant (CFA) twice with an interval of 7 days. At termination on day 21, hearts were collected 
to determine inflammatory changes by H&E staining analysis. Mild myocarditis as indicated by infiltrates containing mononuclear cells (MNCs) were noted in all 
groups. Boxed areas are shown at higher magnifications to the right in each panel. Arrows, inflammatory foci. Scale bar: 120 µm (overview images, 10×), 30 µm 
(magnifications, 40×). (B) Immunohistochemistry. Heart sections obtained from animals immunized with a mixture of β1ARAc 171–190, 181–200, and 211–230 were 
evaluated for the presence of T cells (CD3, CD4, and CD8) and non-T cells (Ly6G+ neutrophils, CD11b+ macrophages and CD19+ B cells) using antibodies for each 
marker or their isotype controls. After washing and addition of horseradish peroxidase (HRP)-conjugated secondary antibodies, cells positive for each marker were 
identified as shown with arrows. Representative sections from groups involving five to eight mice are shown. Naive and CFA/PT, controls; and scale bar, 60 µm.
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FigUre 3 | Determination of major histocompatibility complex (MHC) class II-binding affinities of β1ARAc peptides. Mixtures containing thrombin-cleaved IAk and IEk 
soluble monomers (0.35 µg), competitor peptides—β1ARAc 171–190, β1ARAc 181–200, and β1ARAc 211–230 (0.00001–100 µM)—and biotinylated hen egg lysozyme 
(HEL) 46–61 (reference for IAk) and moth cytochrome c (MCC) 82–103 (reference for IEk) (1 µM) were prepared and added to fluorescence plates coated with anti-IAk 
or IEk in duplicates as described in the methods. After washing, and addition of europium-labeled streptavidin (SA) and dissociation-enhanced lanthanide 
fluoroimmunoassay (DELFIA) enhancer, fluorescence intensities were measured at excitation/emission wavelengths of 340/615 nm to calculate the IC50 values. 
Mean ± SEM values from three individual experiments with two replicates in each are shown. **P < 0.01 and ***P < 0.001 vs. IC50 of IAk/β1ARAc 181–200.
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19–21-mers can act as common epitopes for both CD4 and CD8 
T cells as shown with Myhc 334–352 (31), myelin oligodendro-
cyte glycoprotein 35–55 (52), and interphotoreceptor retinoid-
binding protein 1–20 (53). In the present study however, we did 
not investigate localization of CD8 T cell epitopes in the β1AR 
peptides, and such an identity may then create opportunities to 
determine how CD8 T cells independently or together with CD4 
T cells can induce myocarditis, since their effector functions are 
distinct (CD8 cytotoxic vs. CD4 Th).
Further, we made efforts to characterize CD4 T cell responses 
as to their antigen-specificity. First, we determined MHC class 
II-binding affinities of β1ARAc peptides using soluble MHC 
class-II/IAk and IEk monomers (26, 28, 30). These analyses 
revealed two of the three peptides that induced T cell responses 
(Figure 1) namely, β1ARAc 171–190 and β1ARAc 211–230 could 
bind IAk molecules as indicated by their respective IC50 values, 
26.14 ± 12.41 and 18.64 ± 1.23 µM, whereas the binding affinity 
of β1ARAc 181–200 was low (97.15  ±  2.07  µM) (Figure  3, left 
panel; P < 0.01). Of note, in a comparative analysis, another pep-
tide, β1ARAc 201–220 that did not induce T cell response failed 
to bind IAk molecule (Figure S1B in Supplementary Material), 
and it was not chosen for further characterization. Since, β1ARAc 
181–200, a T  cell activator was found to be a poor binder of 
IAk, we generated IEk monomers to determine its ability to bind 
IEk molecule, since A/J mice express both IAk and IEk molecules 
(33, 34). By using IEk monomers, and MCC 82–103 as a reference 
peptide, we determined that β1ARAc 181–200 to be a good binder 
of IEk molecule as indicated by the IC50 value 6.12 ± 0.69 µM 
(Figure 3, right panel). Based on this information, we decided 
to create two sets of dextramers: IAk dextramers for β1ARAc 
171–190 and β1ARAc 211–230 with RNase 43–56 as control, and 
IEk dextramers for β1ARAc 181–200 and MCC 82–103 (control). 
Using these reagents, we tested the antigen-specificity of T cell 
responses in animals immunized with β1ARAc 171–190, β1ARAc 
181–200, and β1ARAc 211–230, respectively. CD4 T  cells from 
cultures stimulated with the respective peptides were found to 
bind dextramers antigen-specifically, whereas the staining inten-
sity obtained with the control dextramers was low as determined 
by flow cytometry (Figure 4). As we have reported previously 
for various self- and foreign-antigens (28, 34, 35, 54), we noted 
that the dextramers for all the three T cell epitopes of β1AR were 
also preferentially found to bind activated CD4high than CD4low 
subset. The percent dext+ CD4high T cells were: β1ARAc 171–190 
(3.27  ±  0.56%) vs. RNase 43–56 (0.52  ±  0.08%) (P  =  0.049, 
Figure  4A), β1ARAc 181–200 (0.71 ±  0.09%) vs. MCC 82–103 
(0.33  ±  0.03%) (P  =  0.028, Figure  4B), and β1ARAc 211–230 
(0.51  ±  0.01%) vs. RNase 43–56 (0.12  ±  0.01%) (P  =  0.0003, 
Figure  4C). The data point to a possibility that the antigen-
sensitized CD4 T cells might be the mediators of disease.
Next, we sought to determine the pathogenic potential of 
T  cells sensitized with β1AR 171–190, β1AR 181–200, or β1AR 
211–230 by analyzing their ability to produce various inflamma-
tory cytokines (Figure 5). Supernatants from cultures stimulated 
with or without specific or control (RNase 43–56/HEL 46–61) 
antigens revealed the presence of all cytokines, except IL-4. Data 
revealed no striking differences for any of the cytokines except 
that IL-17A was tended to be elevated in β1AR 171–190 and β1AR 
181–200 cultures (P = 0.06, Figure 5). Conversely, production of 
IFN-γ, another key cytokine was not altered including other pro-
inflammatory (IL-6 and TNF-α) or anti-inflammatory (IL-4 and 
IL-10) cytokines. Accumulated literature suggests that IFN-γ can 
act as a disease-protective or disease-inducing cytokine in various 
myocarditis models, and such differential effects may be antigen-
dependent (55). Likewise, IL-17A appears not to be required for 
initiating the disease, but plays a critical role for progression of 
myocarditis (56). We have also seen that cardiac-reactive T cells 
produce mostly IFN-γ (30) and/or IL-17A in addition to IL-6 and 
TNF-α in A/J mice (26, 28). Since, IFN-γ-production was found 
to be unaltered with β1AR peptides, production of IL-17A alone 
might be insufficient to initiate myocarditis which is consistent 
with the observations made in Myhc 614–629-induced myocardi-
tis (56). TNF-α and IL-6, being inflammatory cytokines may have 
a role in myocarditis (57, 58), but their amounts were low in cul-
tures stimulated with β1AR peptides to predict their impact. The 
finding that IL-4 or IL-10 were detected in insignificant amounts 
in all the cultures, suggests that the mild nature of disease in the 
FigUre 4 | Antigen-specificity of T cell responses induced by β1ARAc peptides. Lymph node cells (LNCs) or splenocytes prepared from animals immunized with 
β1ARAc 171–190, β1ARAc 181–200, and β1ARAc 211–230 were restimulated with the corresponding peptides for 2 days and cells were rested in interleukin (IL)-2 
medium. Cells harvested on days 7–10 poststimulation were stained with three sets of dextramers namely, IAk dextramers (β1ARAc 171–190 and RNase 43–56 as 
control), panel (a); IEk dextramers [β1ARAc 181–200 and moth cytochrome c (MCC) 82–103 as control], panel (B); and IAk dextramers (β1ARAc 211–230 with RNase 
43–56 as control), panel (c); followed by staining with anti-CD4 and 7-aminoactinomycin-D (7-AAD). Cells were acquired by flow cytometry, and the dext+ cells were 
analyzed corresponding to CD4low or CD4high populations using Flow Jo software (bar graphs on the right side in each panel). Representative flow cytometric plots 
are shown from two to three individual experiments, with two to five mice per group. *P < 0.05 and ***P < 0.001 vs. control dextramers.
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immunized animals appear not due to immune deviation occur-
ring toward Th2 phenotype.
To investigate whether β1AR-reactive cells producing differ-
ential amounts of Th1 and Th17 cytokines could determine the 
disease outcome, we performed adoptive transfer experiments 
using antigen-primed T cells treated with or without a cocktail 
of cytokines that polarize toward Th1 and Th17 responses 
(41–44). As shown in Figure S4 in Supplementary Material, we 
noted increase in the frequencies of cells expressing Th1 (IL-2 
and IFN-γ) and Th17 (IL-17A and IL-22) including Th2 (IL-4 
and IL-10) cytokines as reported by others (41–44, 59, 60). 
However, comparative analysis revealed Th1-producing cells to 
be significantly enhanced in β1AR 181–200 cultures as opposed 
to Th2 cytokine-producing cells in β1ARAc 171–190 and β1ARAc 
211–230 cultures but with no significant increase in the Th17 
subset in any of the groups. Table  2 shows that the naive 
animals receiving unpolarized lymphocytes specific to β1ARAc 
171–190 and β1ARAc 211–230 had no inflammatory foci in their 
hearts, where as one animal receiving β1ARAc 181–200-primed 
lymphocytes had heart lesions. When the cells were exposed 
FigUre 5 | Cytokine responses induced by β1ARAc peptides. Lymph node cells (LNCs) were prepared from animals immunized with acetylated or non-acetylated 
β1AR 171–190, β1AR 181–200, or β1AR 211–230, and after restimulating with or without the immunizing peptides or RNase 43–56/HEL 46–61 (negative controls), 
culture supernatants were harvested on day 3. Samples were analyzed for indicated cytokines by bead array analysis as described in the methods section. Each bar 
represents mean ± SEM values derived from four to five individual experiments, with three to eight mice per group.
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to the polarizing conditions as described above, it was clear 
that the naive animals receiving β1ARAc 181–200-primed 
lymphocytes had severe myocarditis (25.8 ± 7.4 foci; Table 2; 
Figure 6A; Figure S5 in Supplementary material). Under similar 
conditions, β1ARAc 171–190-and β1ARAc 211–230-responsive 
lymphocytes did not result in disease, which may be due to their 
enhanced ability to produce Th2 cytokines (Table 2; Figure S4 
in Supplementary Material). Expectedly, heart sections from 
control groups (saline and LPS/PT) also were negative for 
inflammatory changes (Table 2; Figure 6A). Furthermore, by 
TaBle 2 | Myocarditis induced by T cells sensitized with β1ARAc peptides in 
naive A/J mice.
groups incidence (%) inflammatory focia
Saline 0/4 (0) 0
LPS/PT 0/4 (0) 0
Unpolarized cells
β1ARAc 171–190 0/4 (0) 0
β1ARAc 181–200 1/4 (25) 6
β1ARAc 211–230 0/4 (0) 0
Th1- and Th17-polarized cells
β1ARAc 171–190 0/4 (0) 0
β1ARAc 181–200 4/4 (100)* 25.8 ± 7.4**
β1ARAc 211–230 1/4 (25) 1
aRepresents mean ± SEM values derived from myocarditic animals.
*P < 0.05 vs. control groups.
**P < 0.01 vs. control groups.
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IHC analysis, we noted detection of CD3+, CD4+ and CD8+ 
T  cells and also CD11b+ macrophages in heart sections from 
animals that received β1ARAc 181–200-primed/polarized lym-
phocytes (Figure 6B). These findings may reinforce the notion 
that the disease induced with β1ARAc peptides represents a 
T  cell-mediated, disease as we have demonstrated with other 
antigens namely, Myhc, ANT, and BCKD kinase (26, 28, 30). 
While, cytokine-polarized experiments provided explanations 
as to why the disease-severity was mild in animals that received 
CFA/β1ARAc peptide emulsions by active immunizations, occur-
rence of disease with only β1ARAc 181–200-sensitized T  cells, 
but not for two other peptides (β1ARAc 171–190 and β1ARAc 
211–230) in adoptive transfer experiments may indicate that 
both Th1 and Th17 cytokines are critical for disease induction. 
Alternatively, it is possible that cytokines other than Th1 and 
Th17 subsets may have a role in the disease-mediation with 
β1ARAc 181–200-sensitized T cells because comparison of fre-
quencies of cytokine-producing cells between groups did not 
reveal striking differences for any of the cytokines tested.
Finally, we evaluated antibody responses for a panel of 
β1ARAc peptides. These include peptides that induced both T cell 
responses and disease (β1ARAc 171–190, β1ARAc 181–200, and 
β1ARAc 211–230), and those that did not induce T cell responses 
or disease (β1ARAc 191–210 and β1ARAc 201–220). Serum 
samples collected from immunized animals were tested for 
their reactivity to the immunizing peptides as indicated above 
or an irrelevant control, RNase 43–56. The analyses revealed 
detection of total Igs specific to β1ARAc peptides, since such 
a reactivity was found lacking for RNase 43–56 (Figure  7A). 
However, comparison of antibody responses between different 
peptides revealed antibody response to β1ARAc 201–220 and to 
some degree, β1ARAc 191–210 (Figure 7A). By further charac-
terizing various isotypes, we noted that the antibody response 
induced with β1ARAc 201–220 involved the production of all 
IgG isotypes (IgG1, IgG2a, IgG2b, IgG3) including IgM, except 
IgA and IgE (Figure 7B). By being a non-T cell activator (Figure 
S1A in Supplementary Material), production of various isotypes 
of Abs specific to β1ARAc 201–220 may mean that the antigen-
specific B cells might have received cytokines from non-T cell 
sources for isotype switching to occur. One potential source is 
the adjuvant (CFA) that can promote isotype switching through 
the secretion of Type I IFNs from dendritic cells as shown previ-
ously (61). Furthermore, it is to be noted that β1ARAc 201–220 
encompasses 20 amino acids of the previously reported B cell 
epitope, β1AR 197–222 that was shown to induce antibodies 
in various rodent species (21, 24, 25). Our data also supports 
this observation. Detection of antibodies to β1ARAc 191–210 
may be due to the presence of overlapping sequence between 
β1ARAc 191–210 and β1ARAc 201–220. However, the observation 
that β1ARAc 201–220 failed to induce myocarditis in our model 
may not necessarily mean that the β1ARAc 201–220-induced 
antibodies are not pathogenic. The reason for this discrepancy 
is that animals needed to be repeatedly immunized with β1ARAc 
197–222 for a period of 12  months in rats and rabbits, and 
mice were also to be immunized with six doses of CFA/peptide 
emulsions (21–25). We did not investigate whether A/J mice 
immunized for such a prolonged period can develop myocardi-
tis, since we limited our focus to the extent of identifying T cell 
epitopes, and their ability to induce myocarditis in a standard 
disease-inducing protocol.
In summary, we demonstrate existence of multiple immuno-
dominant epitopes that are unique to T cells or B cells, but not 
both. Use of a single motif, β1AR 197–222 as a B  cell epitope 
to determine the mechanisms of antibody-mediated myocardial 
disease in several rodent species was perhaps on the idea that 
the epitope was found conserved (Table S1 in Supplementary 
Material). Along the same lines, comparison of sequences 
between humans, mice, rats and rabbits revealed 100% identity for 
all T cell epitopes that we have described namely, β1AR 181–200, 
and β1AR 211–230 with only one residue being different for β1AR 
171–190 between humans and mice (Table S6 in Supplementary 
Material), suggest that these epitopes may be relevant to evaluate 
T cell responses in humans. In addition, we noted that spleno-
cytes from naive animals responded to two out of three T cell 
epitopes namely, β1ARAc 171–190, and β1ARAc 181–200 (Figure 
S6 in Supplementary Material) indicating that the naive reper-
toire can contain a proportion of β1AR-reactive T cells that might 
have responded in response to peptide immunizations. Reports 
suggest that β1AR proteins are differentially expressed in the 
thymus with a predominant form being β2AR (62). It is possible 
that the developing thymocytes may escape from thymic toler-
ance mechanisms due to low β1AR-expression in the thymus 
leading to their emigration to the periphery. Thus, we speculate 
that the preexisting β1AR-reactive T cells can be activated under 
conditions of self-tolerance to be broken by environmental trig-
gers. Of note, cross-reactive immune responses have been noted 
between Trypanosoma cruzi and β1AR and it might be interest-
ing to determine whether such responses are directed against the 
T cell epitopes in A/J mice which are also highly susceptible to 
T. cruzi infection (63, 64). Additionally, we have demonstrated 
that the β1AR-reactive T cells producing insufficient amounts of 
IFN-γ can become pathogenic under Th1-polarized conditions. 
Thus, we could envision a scenario that IL-12 produced by the 
innate immune cells such as macrophages and dendritic cells 
in response to intracellular pathogens like T. cruzi can pos-
sibly trigger IFN-γ-producing β1AR-reactive T cells to become 
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FigUre 6 | Evaluation of hearts for inflammatory changes in naive recipients of T cells sensitized with β1ARAc 181–200. (a) Hematoxylin and eosin (H&E) staining. 
Groups of mice were immunized with a mixture of β1ARAc 171–190, β1ARAc 181–200, and β1ARAc 211–230 and after 14–21 days, lymph node cells (LNCs) were 
restimulated with the corresponding peptides for 2 days. After exposing to T helper (Th)1- and Th17-polarizing conditions, cells harvested on day 7 postpolarization 
and administered into naive mice primed with lipopolysaccharide (LPS). Representative normal heart sections in saline and LPS/PT controls are shown in the top panel. 
The bottom panel represents recipients of β1ARAc 181–200-sensitized/polarized T cells. Circled areas are shown at higher magnifications to the right in each panel 
(arrows, inflammatory foci). Scale bar: 120 µm (overview images, 10×), 30 µm (magnifications, 40×). n = 4 mice per group. (B) Immunohistochemistry. Heart sections 
were examined for T cells and non-T cells using the antibodies for indicated markers. Detection of cells positive for each marker (arrows) was analyzed by adding 
HRP-conjugated secondary antibodies as described in the methods section. Representative sections from four animals in each group are shown. Scale bar, 60 µm.
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pathogenic. Such a possibility exists for three reasons: (a) β1AR 
is preferentially expressed in the heart; (b) evaluation of non-
cardiac tissues such as brain, liver, lung, and kidney in animals 
immunized with β1AR peptides did not reveal any significant 
inflammatory changes relative to control groups (Table S7 in 
Supplementary Material); and (c) all the three T  cell epitopes 
are unique to β1AR because they share only 40–65% similarity 
with β2AR and β3AR (Table S8 in Supplementary Material). Thus, 
the pathogenic β1AR-reactive T  cells are expected to mediate 
damage preferentially in the heart.
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All experiments with mice were performed in accordance with 
the regulations of and with the approval of the Institutional 
Animal Care and Use Committee, University of Nebraska-
Lincoln, Lincoln, NE, USA (protocol #: 1398).
FigUre 7 | Antibody responses induced by β1ARAc peptides. Groups of mice were immunized with β1ARAc 171–190, β1ARAc 181–200, β1ARAc 191–210, β1ARAc 
201–220, or β1ARAc 211–230 and after 21 days, serum was collected. Samples with dilutions of 1:100 were added to low-binding plates coated previously with  
or without the above peptides or RNase 43–56 (control). After adding horseradish peroxidase (HRP)-conjugated, goat anti-mouse detection antibodies for Igs and 
different isotypes, plates were read at 405 nm to measure the OD values. Each bar represents mean ± SEM values derived from five animals per group. **P < 0.01 
vs. controls. (a) Total immunoglobulins and (B) antibody isotypes.
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